Powered by

MeiraGTx Awarded Target ALS Grant For Its NMD-Based Therapy for ALS

Feb 01, 2017 - PR Newswire

MeiraGTx, a New York and UK based gene therapy company, announced today that it has been awarded a grant from Target ALS, a privately funded foundation bringing together a consortia of academic and biotech/pharmaceutical researchers focused on finding treatments for ALS patients. Target ALS is jointly funding this grant with the research organization ALS Finding A Cure�.� The grant will fund testing of a novel gene therapy approach to treat this devastating neurodegenerative disease that tar...